{
    "title": "Malaria Cure",
    "inventor_name": "Gary Posner",
    "publication_year": 2007,
    "device_name": "Trioxane antimalarial compounds (synthetic artemisinin derivatives)",
    "goal": "Provide a curative, single-dose treatment for malaria that is more effective and safer than existing therapies.",
    "problem_addressed": "Rising drug-resistant malaria parasites and the need for longer-acting, curative antimalarial drugs.",
    "concept_summary": "A series of synthetic peroxide (trioxane) compounds modeled on the ancient Chinese herbal remedy artemisinin. The molecules contain an oxygen-oxygen peroxide linkage that, upon encountering heme released by the parasite, generates free radicals that kill the parasite. The new derivatives are designed to be more lipophilic, have a longer half-life, and be less toxic than first-generation endoperoxides.",
    "detailed_description": "Posner's team at Johns Hopkins synthesized semi-synthetic artemisinin-derived trioxanes with enhanced lipophilicity and metabolic stability. In mouse studies a single low dose cured malaria infection, and three oral doses cleared febrile disease. Patent filings (WO2008127381, HK1047047, US7417156) describe various dimers, water-soluble carboxylic acid derivatives, and other analogues that show up to ten-fold higher in-vitro potency than artemisinin and selective anticancer activity. The compounds act by peroxide cleavage in the presence of heme, producing carbon-free radicals that oxidize essential parasite components.",
    "category": "Chemistry & Chemical Processes",
    "principles": [
        "Peroxide-mediated radical generation",
        "Increased lipophilicity for cellular uptake",
        "Extended metabolic half-life"
    ],
    "scientific_domains": [
        "Pharmacology",
        "Medicinal Chemistry",
        "Parasitology"
    ],
    "mechanisms_of_action": [
        "Peroxide cleavage by heme -> free radical formation -> parasite self-destruction",
        "Disruption of parasite hemoglobin digestion pathway"
    ],
    "materials": [
        "Artemisinin",
        "Artemisia annua plant extract",
        "Synthetic trioxane dimers",
        "Carboxylic acid derivatives of trioxanes"
    ],
    "energy_sources": [],
    "inputs": [
        "Malaria-infected mice",
        "Single oral or injectable dose of trioxane compound"
    ],
    "outputs": [
        "Cure of malaria infection in rodents",
        "Reduced parasite load",
        "In-vitro antimalarial potency up to 10x that of artemisinin"
    ],
    "claimed_performance": "Single-dose curative activity in mice; >10-fold higher in-vitro potency than artemisinin; longer half-life and lower toxicity predicted.",
    "experimental_evidence": "Mice infected with malaria were cured after a single low dose of the new compounds; in-vitro assays showed nanomolar activity; patents describe gram-scale synthesis and stability data.",
    "replication_status": null,
    "keywords": [
        "Artemisinin",
        "Trioxane",
        "Peroxide antimalarial",
        "Malaria cure",
        "Semi-synthetic drug",
        "Drug resistance"
    ],
    "related_technologies": [
        "Artemisinin-based combination therapy (ACT)",
        "Endoperoxide antimalarials"
    ],
    "controversy_level": "low",
    "confidence_score": 0.9,
    "practicability_score": 0.7,
    "fringe_score": 0.1,
    "evidence_strength": 0.7,
    "risk_score": 0.2,
    "trl_estimate": 5,
    "source_urls": [
        "http://www.eurekalert.org/pub_releases/2007-04/jhu-mmc041707.php",
        "https://patents.google.com/patent/WO2008127381",
        "https://patents.google.com/patent/HK1047047",
        "https://patents.google.com/patent/US7417156"
    ],
    "organizations": [
        "Johns Hopkins University",
        "National Institutes of Health"
    ],
    "applications": [
        "Human malaria treatment",
        "Antiparasitic therapy",
        "Potential anticancer agents"
    ],
    "limitations": [
        "Efficacy demonstrated only in rodent models",
        "Human safety and pharmacokinetics not yet evaluated",
        "Synthetic route may be costly at scale"
    ],
    "open_questions": [
        "Will the single-dose curative effect translate to humans?",
        "What are the long-term safety profiles of the new peroxide compounds?",
        "Can resistance develop against these trioxanes?"
    ],
    "red_flags": [],
    "evidence_quotes": [
        "Mice cured by 1 dose of new drug",
        "Most important is their curative activity after a single, low dose, which is distinctly unusual.",
        "Alcohol and diol dimers (4 and 5) are 10 times more antimalarially potent in vitro than artemisinin (1).",
        "The oxygen-oxygen unit in the peroxides causes malaria parasites essentially to self-destruct.",
        "These peroxide compounds, containing a crucial oxygen-oxygen unit, promise not only to be more effective than today's best malaria remedies, but also potentially safer and more efficient."
    ]
}